Insufficient scRNA-seq data for expression of RNF183 at single-cell level.
Insufficient scRNA-seq data for expression of RNF183 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 89% | 27.94 | 160 / 180 | 89% | 6.52 | 382 / 430 |
kidney | 100% | 823.94 | 89 / 89 | 71% | 4.39 | 642 / 901 |
intestine | 84% | 36.11 | 815 / 966 | 85% | 4.84 | 448 / 527 |
stomach | 92% | 126.06 | 330 / 359 | 71% | 3.16 | 203 / 286 |
thymus | 95% | 37.20 | 619 / 653 | 48% | 1.95 | 293 / 605 |
pancreas | 59% | 15.20 | 194 / 328 | 77% | 4.34 | 137 / 178 |
uterus | 84% | 52.25 | 142 / 170 | 47% | 4.79 | 217 / 459 |
esophagus | 73% | 143.96 | 1059 / 1445 | 55% | 2.54 | 101 / 183 |
bladder | 81% | 27.57 | 17 / 21 | 44% | 2.45 | 223 / 504 |
breast | 78% | 95.49 | 358 / 459 | 40% | 3.15 | 446 / 1118 |
lung | 74% | 30.26 | 426 / 578 | 40% | 2.38 | 462 / 1155 |
prostate | 94% | 88.29 | 230 / 245 | 1% | 0.02 | 7 / 502 |
skin | 70% | 25.53 | 1272 / 1809 | 0% | 0.01 | 1 / 472 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.00 | 17 / 29 |
adrenal gland | 53% | 11.76 | 136 / 258 | 0% | 0 | 0 / 230 |
adipose | 50% | 10.56 | 601 / 1204 | 0% | 0 | 0 / 0 |
brain | 46% | 10.05 | 1208 / 2642 | 1% | 0.05 | 7 / 705 |
liver | 32% | 5.92 | 73 / 226 | 7% | 0.22 | 27 / 406 |
blood vessel | 38% | 7.76 | 511 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 1.65 | 12 / 45 |
spleen | 21% | 3.65 | 51 / 241 | 0% | 0 | 0 / 0 |
heart | 16% | 2.97 | 141 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 11% | 17.90 | 101 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.23 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_1902237 | Biological process | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0033106 | Cellular component | cis-Golgi network membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF183 |
Protein name | E3 ubiquitin-protein ligase RNF183 (EC 2.3.2.27) |
Synonyms | |
Description | FUNCTION: Acts as an E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins . Triggers apoptosis in response to prolonged ER stress by mediating the polyubiquitination and subsequent proteasomal degradation of BCL2L1 . May collaborate with FATE1 to restrain BIK protein levels thus regulating apoptotic signaling . . |
Accessions | ENST00000489339.2 ENST00000478815.1 Q96D59 ENST00000441031.3 ENST00000416588.2 ENST00000297894.5 |